- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Snapshot for ABIOMED Inc (ABMD)
| Open: | 21.9500 | Day's Range: | 20.2700 - 21.9500 | Volume: | 1,239,535 | Bid: | 20.8000 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 21.9200 | 52wk Range: | 9.9800 - 26.1700 | 1-Yr Rtn: | +12.25% | Ask: | 20.8100 |
Key Statistics for ABMD
| Current P/E Ratio (ttm) | 2,079.9999 |
|---|---|
| Estimated P/E (03/2013) | 60.1156 |
| Earnings Per Share (USD) (ttm) | 0.0100 |
| Est. EPS (USD) (03/2013) | 0.3460 |
| Est. PEG Ratio | 2.4046 |
| Market Cap (M USD) | 811.08 |
| Shares Outstanding (M) | 38.99 |
| Enterprise Value (M USD) (ttm) | 733.85 |
| Enterprise Value/EBITDA (ttm) | 137.55 |
| Price/Book (mrq) | 6.4679 |
| Price/Sale (ttm) | 6.3353 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/03/2012 |
More ABMD Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for ABMD
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for ABMD
ABIOMED, Inc. develops, manufactures, and markets cardiovascular products. The Company's BVS-5000 is a cardiac assistance device for patients with reversible heart failure. ABIOMED is also developing its AbioCor implantable replacement heart, which is intended to extend the lives of patients with irreversible end- stage heart failure.
| Michael R MinogueChairman/President/CEO | David M WeberChief Operating Officer |
| William J BoltSenior VP:Engineering | Robert L BowenVP/CFO/Treasurer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page